Dulaglutide dosage: reported doses and schedule

A weekly GLP-1 medicine approved for type 2 diabetes and lower heart-event risk.

Also called: Trulicity, LY2189265.

GLP-1 / GIP / glucagon agonists · GLP-1 receptor agonist · Evidence: Approved drug.

Typical reported dose: 0.75 mg once a week to start, up to 4.5 mg

  • Trulicity: adult label only: 0.75 mg once weekly, then 1.5 mg once weekly, if needed, then 3 mg once weekly, if needed, then 4.5 mg once weekly, if needed once weekly, under the skin. Drug label. Studied in: Adults with type 2 diabetes. (source)
  • Early trial: 0.1 mg weekly: 0.1 mg once weekly; fixed assigned dose. once weekly, under the skin. Studied in a trial. Studied in: Adults with type 2 diabetes on no other glucose medicine. (source)
  • Early trial: 0.5 mg weekly: 0.5 mg once weekly; fixed assigned dose. once weekly, under the skin. Studied in a trial. Studied in: Adults with type 2 diabetes on no other glucose medicine. (source)
  • Early trial: 1 mg weekly: 1 mg once weekly; fixed assigned dose. once weekly, under the skin. Studied in a trial. Studied in: Adults with type 2 diabetes on no other glucose medicine. (source)
  • Early trial: 1.5 mg weekly: 1.5 mg once weekly; fixed assigned dose. once weekly, under the skin. Studied in a trial. Studied in: Adults with type 2 diabetes on no other glucose medicine. (source)
  • EGO: 0.5 to 1: 0.5 mg once weekly, then 1 mg once weekly once weekly, under the skin. Studied in a trial. Studied in: Adults with type 2 diabetes taking two oral drugs. (source)

These are doses reported in labels, trials or user reports, not a personal plan. Check the source behind each one.

Work out syringe units with the dosing calculator

Related to Dulaglutide

Sources

Sources checked: 2026-10-18.

Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.